Business & Regulation

The FDA has approved its first biosimilar of 2020: Pfizer’s Nyvepria (pegfilgrastim-apgf).

How is the business of making medicine changing in light of the COVID-19 pandemic?

Sitting Down With... JoyL Silva, General Manager at PfizerCentre.

Sitting Down With… Bobby Sheng, Chairman and CEO of Bora Pharmaceuticals, Taiwan.

How Raman spectroscopy-based technologies enable the pharma industry to streamline analytical workflows.

Sitting Down With... Kelly Chibale, Director, H3D, University of Cape Town, South Africa.

In under two months, the ISCT managed to pull together a gamified virtual conference platform.

The Global Vaccine Summit raised funds to improve international immunization programs.

Business insurance exists to help companies when unexpected events and damages occur – so you need to have the right policy in place.

EMA reviews lessons learned from nitrosamine impurities.